Lv7
3330 积分 2022-05-17 加入
The landscape for in vivo CAR T cell therapies
6天前
已关闭
The landscape for in vivo CAR T cell therapies
6天前
已完结
An apples-to-apples comparison of VHH and scFv antigen-binding domains in CAR-T cells
11天前
已完结
Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
13天前
已完结
Rewiring immunity with in vivo CAR T cell engineering
13天前
已完结
Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response
13天前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
20天前
已完结
Intracranial delivery of B7-H3-targeting CAR-T cells for recurrent glioblastoma: a phase 1 trial
27天前
已完结
Targeting systemic IL-2 to BCMA CAR-T cells
1个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
1个月前
已完结
皖公网安备34019202002308
